Current status of immunological monitoring in the renal allograft recipient

With the appropriate combined use of different immune monitoring techniques, it is possible to derive sensitive diagnostic parameters for the transplant surgeon. However, the core biopsy or cytological examination of the graft continues to represent the gold standard for evaluating the specificity and sensitivity of these methods. With the development of newer monoclonal antibodies and a better understanding of the impact of immune processes on the behavior of various activation linked. T cell associated surface antigens, one may be able to secure further valuable information, with enhanced diagnostic and prognostic accuracy.